EVA Airways vs Jazz Pharmaceuticals Which Performs Better?

EVA Airways Corporation is a Taiwanese airline company that has been in operation since 1989, providing passenger and cargo services to destinations worldwide. On the other hand, Jazz Pharmaceuticals is a biopharmaceutical company based in Ireland, specializing in the development and commercialization of novel medications for various medical conditions. Both companies are publicly traded on the stock market, offering investors the opportunity to potentially profit from their respective industries. This comparison will analyze the performance of EVA Airways and Jazz Pharmaceuticals stocks, evaluating factors such as financial health, growth potential, and market trends.

EVA Airways or Jazz Pharmaceuticals?

When comparing EVA Airways and Jazz Pharmaceuticals, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between EVA Airways and Jazz Pharmaceuticals.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. EVA Airways has a dividend yield of 3.92%, while Jazz Pharmaceuticals has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. EVA Airways reports a 5-year dividend growth of 35.04% year and a payout ratio of 0.00%. On the other hand, Jazz Pharmaceuticals reports a 5-year dividend growth of 0.00% year and a payout ratio of 24.24%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with EVA Airways P/E ratio at 9.37 and Jazz Pharmaceuticals's P/E ratio at 15.93. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. EVA Airways P/B ratio is 2.13 while Jazz Pharmaceuticals's P/B ratio is 1.77.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, EVA Airways has seen a 5-year revenue growth of 0.03%, while Jazz Pharmaceuticals's is 0.92%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with EVA Airways's ROE at 24.76% and Jazz Pharmaceuticals's ROE at 12.06%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are NT$45.50 for EVA Airways and $118.66 for Jazz Pharmaceuticals. Over the past year, EVA Airways's prices ranged from NT$29.95 to NT$48.25, with a yearly change of 61.10%. Jazz Pharmaceuticals's prices fluctuated between $99.06 and $134.17, with a yearly change of 35.44%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.